<style face="normal" font="default" size="100%">Discontinuation and switching of therapy after initiation of lipid-lowering drugs: the effects of comorbidities and patient characteristics</style>

Drupal-Bibcite

31<style face="normal" font="default" size="100%">Discontinuation and switching of therapy after initiation of lipid-lowering drugs: the effects of comorbidities and patient characteristics</style><style face="normal" font="default" size="100%">Discontinuation and switching of therapy after initiation of lipid-lowering drugs: the effects of comorbidities and patient characteristics</style>